Diagnósticos da América S.A - Asset Resilience Ratio
Diagnósticos da América S.A (DASA3) has an Asset Resilience Ratio of 10.42% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read DASA3 total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2024)
This chart shows how Diagnósticos da América S.A's Asset Resilience Ratio has changed over time. See DASA3 book value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Diagnósticos da América S.A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see DASA3 market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | R$2.20 Billion | 10.42% |
| Short-term Investments | R$0.00 | 0% |
| Total Liquid Assets | R$2.20 Billion | 10.42% |
Asset Resilience Insights
- Moderate Liquidity: Diagnósticos da América S.A has 10.42% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Diagnósticos da América S.A Industry Peers by Asset Resilience Ratio
Compare Diagnósticos da América S.A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY |
Diagnostics & Research | 0.00% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Fleury S.A.
SA:FLRY3 |
Diagnostics & Research | 16.19% |
|
Shanghai Labway Clinical Laboratory Co Ltd
SHE:301060 |
Diagnostics & Research | 2.10% |
|
Genoray Co. Ltd
KQ:122310 |
Diagnostics & Research | 0.03% |
|
Bcal Diagnostics Ltd
AU:BDX |
Diagnostics & Research | 0.00% |
|
Avricore Health Inc
V:AVCR |
Diagnostics & Research | 0.75% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
Annual Asset Resilience Ratio for Diagnósticos da América S.A (2000–2024)
The table below shows the annual Asset Resilience Ratio data for Diagnósticos da América S.A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 6.54% | R$1.73 Billion ≈ $339.67 Million |
R$26.46 Billion ≈ $5.19 Billion |
+1.87pp |
| 2023-12-31 | 4.68% | R$1.23 Billion ≈ $240.53 Million |
R$26.21 Billion ≈ $5.14 Billion |
-5.30pp |
| 2022-12-31 | 9.98% | R$2.68 Billion ≈ $525.73 Million |
R$26.84 Billion ≈ $5.27 Billion |
-4.23pp |
| 2021-12-31 | 14.21% | R$3.30 Billion ≈ $648.25 Million |
R$23.25 Billion ≈ $4.56 Billion |
+3.46pp |
| 2020-12-31 | 10.75% | R$1.43 Billion ≈ $281.39 Million |
R$13.34 Billion ≈ $2.62 Billion |
+1.13pp |
| 2019-12-31 | 9.62% | R$850.52 Million ≈ $166.89 Million |
R$8.84 Billion ≈ $1.73 Billion |
-4.99pp |
| 2018-12-31 | 14.61% | R$1.06 Billion ≈ $207.08 Million |
R$7.22 Billion ≈ $1.42 Billion |
+5.30pp |
| 2017-12-31 | 9.31% | R$581.66 Million ≈ $114.13 Million |
R$6.25 Billion ≈ $1.23 Billion |
-3.24pp |
| 2016-12-31 | 12.55% | R$648.00 Million ≈ $127.15 Million |
R$5.16 Billion ≈ $1.01 Billion |
+9.14pp |
| 2015-12-31 | 3.41% | R$159.56 Million ≈ $31.31 Million |
R$4.68 Billion ≈ $918.65 Million |
-0.18pp |
| 2014-12-31 | 3.58% | R$165.24 Million ≈ $32.42 Million |
R$4.61 Billion ≈ $904.47 Million |
+2.03pp |
| 2013-12-31 | 1.56% | R$72.98 Million ≈ $14.32 Million |
R$4.69 Billion ≈ $920.62 Million |
+0.81pp |
| 2012-12-31 | 0.75% | R$31.95 Million ≈ $6.27 Million |
R$4.27 Billion ≈ $838.28 Million |
-0.22pp |
| 2011-12-31 | 0.97% | R$41.37 Million ≈ $8.12 Million |
R$4.28 Billion ≈ $840.36 Million |
-1.58pp |
| 2010-12-31 | 2.54% | R$49.46 Million ≈ $9.70 Million |
R$1.94 Billion ≈ $381.63 Million |
-13.98pp |
| 2009-12-31 | 16.52% | R$273.70 Million ≈ $53.71 Million |
R$1.66 Billion ≈ $325.11 Million |
-9.36pp |
| 2008-12-31 | 25.88% | R$478.75 Million ≈ $93.94 Million |
R$1.85 Billion ≈ $362.95 Million |
+23.96pp |
| 2007-12-31 | 1.92% | R$23.40 Million ≈ $4.59 Million |
R$1.22 Billion ≈ $239.08 Million |
-30.03pp |
| 2006-12-31 | 31.95% | R$325.49 Million ≈ $63.87 Million |
R$1.02 Billion ≈ $199.88 Million |
+23.72pp |
| 2005-12-31 | 8.23% | R$48.17 Million ≈ $9.45 Million |
R$585.13 Million ≈ $114.81 Million |
-14.95pp |
| 2004-12-31 | 23.19% | R$123.25 Million ≈ $24.18 Million |
R$531.60 Million ≈ $104.31 Million |
+16.09pp |
| 2003-12-31 | 7.09% | R$25.15 Million ≈ $4.94 Million |
R$354.72 Million ≈ $69.60 Million |
-3.23pp |
| 2002-12-31 | 10.32% | R$33.94 Million ≈ $6.66 Million |
R$328.84 Million ≈ $64.52 Million |
+4.96pp |
| 2001-12-31 | 5.36% | R$14.11 Million ≈ $2.77 Million |
R$263.43 Million ≈ $51.69 Million |
+5.30pp |
| 2000-12-31 | 0.06% | R$87.00K ≈ $17.07K |
R$158.04 Million ≈ $31.01 Million |
-- |
About Diagnósticos da América S.A
Diagnósticos da América S.A., together with its subsidiaries, provides diagnostic and hospital services in Brazil and Argentina. It operates through Hospitals and Oncology; Diagnostics and Care Coordination; and International Diagnostics segments. The company offers outpatient doctors; medical and outpatient services; diagnostic support assistants for private patients or partner companies; care c… Read more